Welcome to LookChem.com Sign In|Join Free
  • or
Phenyl(1-(propylamino)cyclopentyl)methanone is a complex organic compound with the molecular formula C18H25NO. It is a derivative of cyclopentylketone, featuring a phenyl group attached to the carbonyl carbon and a propylamino group connected to the cyclopentyl ring. phenyl(1-(propylamino)cyclopentyl)methanone is known for its potential applications in the synthesis of pharmaceuticals and other chemical products due to its unique structure. It is a white crystalline solid that is insoluble in water but soluble in organic solvents. The compound's properties, such as its reactivity and stability, make it a valuable intermediate in the preparation of various chemical compounds.

7141-84-6

Post Buying Request

7141-84-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7141-84-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7141-84-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,4 and 1 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7141-84:
(6*7)+(5*1)+(4*4)+(3*1)+(2*8)+(1*4)=86
86 % 10 = 6
So 7141-84-6 is a valid CAS Registry Number.

7141-84-6Downstream Products

7141-84-6Relevant academic research and scientific papers

Improved methods for thermal rearrangement of alicyclic α-hydroxyimines to α-aminoketones: Synthesis of ketamine analogues as antisepsis candidates

Elhawi, Hagit,Eini, Hadar,Douvdevani, Amos,Byk, Gerardo

, p. 6784 - 6807 (2012/09/07)

Ketamine is an analgesic/anesthetic drug, which, in combination with other drugs, has been used as anesthetic for over 40 years. Ketamine induces its analgesic activities by blocking the N-methyl-D-aspartate (NMDA) receptor in the central nervous system (CNS). We have reported that low doses of ketamine administrated to patients before incision significantly reduced post-operative inflammation as reflected by reduced interleukin-6 (IL-6) sera-levels. Our data demonstrated in a rat model of Gram-negative bacterial-sepsis that if we inject a low dose of ketamine following bacterial inoculation we reduce mortality from approximately 75% to 25%. Similar to what we have observed in operated patients, the levels of TNF-α and IL-6 in ketamine-treated rats were significantly lower than in septic animals not treated with ketamine. On the base of these results, we have designed and synthesized series of new analogues of ketamine applying a thermal rearrangement of alicyclic α-hydroxyimines to α-aminoketones in parallel arrays. One of the analogues (compound 6e) displayed high activity in down-regulating the levels of IL-6 and TNF-α in vivo as compared to ketamine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7141-84-6